Skip to main navigationSkip to main content
The University of Southampton
ATTACK Trial

ATTACK: ASPIRIN TO TARGET ARTERIAL EVENTS IN CHRONIC KIDNEY DISEASE

Does low-dose aspirin reduce the chance of a first heart attack or stroke in patients with chronic kidney disease (CKD)?

 

This is a large-scale academic study, being led by the University of Southampton, to see whether or not patients with chronic kidney disease should take aspirin daily to prevent a first heart attack or stroke. It is recruiting patients from GP practices across the UK, and looks to invite 198,000 patients.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×